BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27811508)

  • 1. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
    van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
    Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.
    Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Wijnhoven BP; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2014 Oct; 40(10):1338-45. PubMed ID: 24484779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].
    van Putten M; Verhoeven RHA; Koëter M; van Laarhoven HWM; van Sandick JW; Plukker JTM; Siersema PD; Hulshof MCCM; Wijnhoven BPL; Lemmens VEPP; Nieuwenhuijzen GAP
    Ned Tijdschr Geneeskd; 2018; 162():D1970. PubMed ID: 29600921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
    Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
    Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.
    van Putten M; Verhoeven RH; van Sandick JW; Plukker JT; Lemmens VE; Wijnhoven BP; Nieuwenhuijzen GA
    Br J Surg; 2016 Feb; 103(3):233-41. PubMed ID: 26621158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
    Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
    Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
    Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation, Treatment, and Prognosis of Esophageal Carcinoma in a Nationwide Comparison of Sweden and the Netherlands.
    Kalff MC; Gottlieb-Vedi E; Verhoeven RHA; van Laarhoven HWM; Lagergren J; Gisbertz SS; Markar SR; van Berge Henegouwen MI
    Ann Surg; 2021 Nov; 274(5):743-750. PubMed ID: 34353984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
    Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer.
    Faiz Z; van Putten M; Verhoeven RHA; van Sandick JW; Nieuwenhuijzen GAP; van der Sangen MJC; Lemmens VEPP; Wijnhoven BPL; Plukker JTM
    Ann Surg Oncol; 2019 Apr; 26(4):986-995. PubMed ID: 30719634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
    Njei B; McCarty TR; Birk JW
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
    van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL;
    Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient education-level affects treatment allocation and prognosis in esophageal- and gastroesophageal junctional cancer in Sweden.
    Linder G; Sandin F; Johansson J; Lindblad M; Lundell L; Hedberg J
    Cancer Epidemiol; 2018 Feb; 52():91-98. PubMed ID: 29278841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of socioeconomic status on staging and treatment decisions in esophageal cancer.
    Bus P; Aarts MJ; Lemmens VE; van Oijen MG; Creemers GJ; Nieuwenhuijzen GA; van Baal JW; Siersema PD
    J Clin Gastroenterol; 2012; 46(10):833-9. PubMed ID: 22460163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study.
    Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Nieuwenhuijzen GA
    Cancer Epidemiol; 2015 Dec; 39(6):863-9. PubMed ID: 26651448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcome of young patients with esophageal cancer in the Netherlands.
    van Nistelrooij AM; van Steenbergen LN; Spaander MC; Tilanus HW; van Lanschot JJ; Lemmens VE; Wijnhoven BP
    J Surg Oncol; 2014 May; 109(6):561-6. PubMed ID: 24338660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA.
    Molena D; Stem M; Blackford AL; Lidor AO
    J Gastrointest Surg; 2017 Jan; 21(1):126-136. PubMed ID: 27527093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
    Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.